📰 Andreask Lauer News
Andreask Lauer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreask Lauer. Real-time updates on events, politics, business and more.
May 6, 2024
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
May 6, 2024
BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy
March 28, 2024
703-Carat LHeure Bleu Tanzanite Carving Sets New GUINNESS WORLD RECORDS(TM) ...
May 25, 2022
FORT LAUDERDALE, Fla. — Best practices for safe subretinal delivery of gene therapy were presented at the Retina World Congress.
June 2, 2021
When Iveric Bio established its gene therapy advisory committee recently, the move signaled the opening of a second front in its mission to treat retinal diseases for which there are no treatments.
May 21, 2021
Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers. AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Pr...